Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of…
French biotech company Onxeo S.A. has given an update on the clinical development program of…
Clinical-stage bio company, Onxeo, has announced that the first patients have been enrolled and treated…
Paris-based Onxeo has proved in humans the potential of a cancer treatment that interferes with…
Onxeo has initiated a Phase I trial testing its first-in-class cancer treatment that works by…
Onxeo has announced Phase III results for its nanoparticle chemotherapy Livatag, which failed to improve…
Today is the World Blood Cancer Day, an event to show solidarity to patients and…
Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers.…
We are all familiar with stories of lawsuits in the tech sector (e.g. remember the…
Onxeo, an innovative company specializing in the development of orphan oncology drugs, founded after the…